The three questions you should be asking about outcomes
With more opportunities than ever to reach learners online, it’s important for medical teams to evaluate how online CEs are meeting goals. Read More
PlatformQ Health presents e-poster presentation on SMA at the Rare Disease Day at NIH 2021 virtual event
Rare Disease Day at NIH aims to raise awareness about rare diseases, the people they affect, and highlights the recent research collaborations to address challenges and advances in new treatments. Read More
World Rare Disease Day – Sharing our digital program library with the rare disease community
Together, over the years, NORD and PlatformQ Health have closely collaborated to produce a multitude of digital resources for healthcare professionals, patients, and families to facilitate timely diagnosis and improved care. Read More
A Changing World: A Look Back on 2020
In 2020, PlatformQ Health’s mission to improve health outcomes through trusted digital education did not waver. We are grateful to be a steady hand for our partners, HCP and patient learners, and supporters, providing continuity through seamless shifts into the digital world. Digital education is at the heart of our past and current success, and our ability to adapt and innovate is a critical component of our future-focused orientation. Read More
NORD, FDA, and CDC Leaders Provide Rare Disease Community COVID-19 Vaccine Education Leveraging PlatformQ Health’s CONDUIT Solution
While the COVID-19 pandemic has been socially and economically devastating for us all, the rare-disease community faces a unique set of challenges. Seeking to address these challenges, the National Organization for Rare Disorders (NORD) leveraged Conduit - PlatformQ Health’s proprietary engagement platform - to host the webinar, COVID-19 Vaccines Update: FDA and CDC Leaders Address the Rare Disease Community. Read More
PlatformQ Health, the American Migraine Foundation and the National Headache Foundation collaborate on a new tethered digital educational program
PlatformQ Health is launching, “Aligned Health Care Provider and Patient Education on Calcitonin Gene-Related Peptide-Targeted Treatment of Migraine,” a new digital tethered education program, produced in collaboration with the American Migraine Foundation and the National Headache Foundation on January 22, 2021. Read More
Digital health education in 2021: Driving impact through purposeful design
Our world will be different in 2021 and beyond. The question is, how will we, as a health education community, evolve? Here we are, finally, in 2021. For months we looked forward to turning a new year and imagined life where we are not jumping from crisis to crisis—put simply, life that just feels normal. Read More
PlatformQ Health ends 2020 with 15 new digital education programs in 5 different therapeutic areas
PlatformQ Health celebrates a busy end to 2020 with 15 digital programs in the month of December, including both accredited online healthcare provider activities and patient education sessions. Read More
2020: A year of innovation
From patients to caregivers, associations to pharmaceutical companies, COVID-19 ignited transformative digital innovations across healthcare. Robert Rosenbloom, our CEO, reflects on 2020 and looks to the year ahead. Read More
Tethered education: Closing the gap between patients and providers
Under normal circumstances, managing a complicated health condition can be challenging enough with limited in-person time. Now with COVID-19, doctors are scrambling for new strategies to provide care to their patients, leading to a dramatic increase in the reliance on telemedicine. One solution gaining traction: Tethered education. Read More
PlatformQ Health launches 4-part clinician online education series on strategies to adapt eye care during COVID-19
PlatformQ Health partnered with the American Macular Degeneration Foundation, Opthalmology360, and BroadcastMed to produce a 4-part CME activity. Read More
First-Ever Digital Rare Cancer Congress Benefits Clinicians from Across the United States
The digital Rare Cancer Congress, held on October 28th and November 12th, engaged community-based clinicians and oncologists in 2 focused tracks on rare hematologic malignancies and rare solid tumors which encompassed 9 interactive, expert-led discussions. Read More
